Kurt Von Emster's Net Worth
Kurt Von Emster's net worth is estimated to be at least $82,674,404.54 as of 12/24/2024. CoreStreet's estimation of Kurt Von Emster's net worth is based on their sale of stock and current holding of stock.
Kurt Von Emster is Director at Cymabay Therapeu. They have executed at least 41 trades of stock as per SEC Form 4 filings. Their most recent trade was for 15,921 units of CBAY stock on 09/29/2023. Their biggest sale was on 05/14/2018 when they sold 650,000 units of Crispr Therapeutics AG stock for $35,353,500.00. They typically trade 13 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $82,674,404.54
Most recent insider trade:
- Sept. 29, 2023
Kurt Von Emster's Insider Trading History
| Cymabay Therapeu | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 29, 2023 | Director | 15,921 | $15.68 | Sell | $249,641.28 |
Dec. 18, 2018 | Director | 142,381 | $7.89 | Sell | $1,123,386.09 |
June 5, 2018 | Director | 920 | $12.51 | Sell | $11,509.20 |
March 5, 2018 | Director | 13,353 | $15.51 | Sell | $207,105.03 |
Feb. 14, 2018 | Director | 218,057 | $15.89 | Sell | $3,464,925.73 |
Feb. 7, 2018 | Director | 40,763 | $12.35 | Sell | $503,423.05 |
Feb. 5, 2018 | Director | 18,831 | $12.14 | Sell | $228,608.34 |
Feb. 2, 2018 | Director | 90,098 | $12.15 | Sell | $1,094,690.70 |
Jan. 31, 2018 | Director | 97,639 | $12.22 | Sell | $1,193,148.58 |
Jan. 25, 2018 | Director | 39,438 | $12.18 | Sell | $480,354.84 |
Jan. 22, 2018 | Director | 138,253 | $10.40 | Sell | $1,437,831.20 |
Jan. 19, 2018 | Director | 144,216 | $10.25 | Sell | $1,478,214.00 |
Jan. 5, 2018 | Director | 4,300 | $10.21 | Sell | $43,903.00 |
Dec. 22, 2017 | Director | 173,192 | $9.41 | Sell | $1,629,736.72 |
Nov. 10, 2017 | Director | 50,048 | $9.26 | Sell | $463,444.48 |
Oct. 31, 2017 | Director | 59,209 | $9.27 | Sell | $548,867.43 |
Oct. 3, 2017 | Director | 108,876 | $7.85 | Sell | $854,676.60 |
Sept. 29, 2017 | Director | 211,124 | $8.09 | Sell | $1,707,993.16 |
| Crispr Therapeutics AG | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 18, 2018 | Director | 72,934 | $29.85 | Sell | $2,177,079.90 |
June 5, 2018 | Director | 920 | $12.51 | Sell | $11,509.20 |
May 14, 2018 | Director | 650,000 | $54.39 | Sell | $35,353,500.00 |
May 11, 2018 | Director | 250,000 | $52.84 | Sell | $13,210,000.00 |
Jan. 5, 2018 | Director | 92,337 | $26.96 | Sell | $2,489,405.52 |
Jan. 2, 2018 | Director | 37,754 | $26.76 | Sell | $1,010,297.04 |
Aug. 28, 2017 | Director | 88,011 | $19.79 | Sell | $1,741,737.69 |
Aug. 25, 2017 | Director | 22,781 | $19.42 | Sell | $442,407.02 |
Aug. 23, 2017 | Director | 17,989 | $18.53 | Sell | $333,336.17 |
Aug. 21, 2017 | Director | 3,150 | $18.52 | Sell | $58,338.00 |
Aug. 17, 2017 | Director | 34,141 | $19.06 | Sell | $650,727.46 |
Aug. 15, 2017 | Director | 55,569 | $19.59 | Sell | $1,088,596.71 |
Aug. 8, 2017 | Director | 35,473 | $18.63 | Sell | $660,861.99 |
Aug. 4, 2017 | Director | 50,477 | $17.81 | Sell | $898,995.37 |
Aug. 1, 2017 | Director | 5,512 | $17.51 | Sell | $96,515.12 |
July 28, 2017 | Director | 41,312 | $17.63 | Sell | $728,330.56 |
July 26, 2017 | Director | 32,930 | $17.60 | Sell | $579,568.00 |
July 14, 2017 | Director | 69,859 | $16.84 | Sell | $1,176,425.56 |
July 12, 2017 | Director | 31,992 | $16.56 | Sell | $529,787.52 |
July 5, 2017 | Director | 4,254 | $16.26 | Sell | $69,170.04 |
June 29, 2017 | Director | 43,202 | $16.90 | Sell | $730,113.80 |
June 27, 2017 | Director | 81,435 | $17.08 | Sell | $1,390,909.80 |
June 23, 2017 | Director | 32,368 | $16.23 | Sell | $525,332.64 |